Latest Stock Split Details
Key information about Gene Biotherapeutics, Inc.'s most recent stock split
Split Date: 2013-07-18
Split Ratio: 1:20
Price Before Split: $0.07
Price After Split: $0.00
Developer API
Get CRXM split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/CRXM
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Gene Biotherapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2013-07-18 | 1:20 | Yes | $0.07 | $0.00 |
About Gene Biotherapeutics, Inc.
Company overview and industry information
Gene Biotherapeutics, Inc. (CRXM) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Gene Biotherapeutics, Inc. Summary